| Business Name: |
Chesapeake Pharmaceutical |
| Contact Person: |
Jim Kotek, Chief Executive Officer |
| Address: |
6 Commerce Road, Fairfield, New Jersey 07004 |
| Phone Number: |
(973) 808-8000 |
| Website Address: |
cortegra.com |
| Annual Revenue (USD): |
$10.000.000 to $19.9999.999 |
| Location Type: |
Branch |
| Employee Number: |
1 to 4 |
| Business Type: |
B2B (Business to Business) |
| Business Category: |
Printers |
| SIC Code: |
2752 |
| NAICS Code: |
5619100 |
| Share This Business: |
|
| Related Businesses: |
S1 Print Solutions LLC - Fairfield, NJ 07004
Delaser Printing Systems Inc - Fairfield, NJ 07004
Harvard Printing Group - Fairfield, NJ 07004
Nordicom Inc - Fairfield, NJ 07004
Drew Rogers Inc - Fairfield, NJ 07004
Repromatic Printing - Fairfield, NJ 07004
All Print Resources Group Inc - Fairfield, NJ 07004
Gms Litho - Fairfield, NJ 07004
Insty-Prints - Fairfield, NJ 07004
All Print Resources - Fairfield, NJ 07004
Fairfield Litho II Corp - Fairfield, NJ 07004
Steve Litvany Printing - Fairfield, NJ 07004
Jayton Printing Co - Fairfield, NJ 07004
Dill Communications Inc - Fairfield, NJ 07004
Columbia Press Inc - Fairfield, NJ 07004
Minolta Business Sys - Fairfield, NJ 07004
N J - Fairfield, NJ 07004
Class Act Embroidery & Screen - Fairfield, NJ 07004
|
The company Chesapeake Pharmaceutical provides B2B services in the form of Printers from its branch in New Jersey.
1 to 4 employees work for Chesapeake Pharmaceutical, and the business now earns $10.000.000 to $19.9999.999 per annum.
Chesapeake Pharmaceutical was launched in 0 and is classified under SIC code and category 2752 , and NAICS number and grouping 5619100 .
To contact Chesapeake Pharmaceutical, please call Jim Kotek, Chief Executive Officer with the phone number (973) 808-8000 or visit its branch at 6 Commerce Road in Fairfield, New Jersey 07004.
The location of the branch can also be found using the coordinates 40.87238,-74.31502.
Read more details about this business on the webpage cortegra.com or follow the company’s social media accounts, on Twitter and on Facebook.